Drug Database
Back to search

Belgium· BE-AMP-SAM253583-00

Prismasol 2 mmol/l Potassium

A hemofiltrates product containing lactic acid, registered in Belgium by Vantive Belgium. The same ATC class is registered in 11 of our 19 countries.

ATC B05ZB

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedPrismasol 2 mmol/l PotassiumATCB05ZBREGISTER NO.BE-AMP-SAM253583-00PACKS LISTED1CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about lactic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Lactic acid is registered in 11 of 19 countries.

Countries holding a registration under ATC B05ZB (hemofiltrates), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose
Search lactic acid products by name

Lactic acid · ATC B05ZB

11 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Lactic Acid
Manufacturer
Vantive Belgium
Country
Belgium (BE)
ATC code
B05ZB
ATC class
Hemofiltrates
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4197414

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lactic acid in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lactic acid products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/cb8f6e4a-4d47-41fa-ac97-f3ebb4f75373
GET /v1/drugs/cb8f6e4a-4d47-41fa-ac97-f3ebb4f75373?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for haemodialysis/haemofiltration",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Prismasol 2 mmol/l Potassium",
  "name_fr": "Prismasol 2 mmol/l Potassium",
  "name_nl": "Prismasol 2mmol/l Kalium",
  "amp_code": "SAM253583-00",
  "strengths": [
    "0.2700",
    "5.1450",
    "5.1450",
    "1.1000",
    "2.9400",
    "0.2700",
    "0.1017",
    "0.1017",
    "0.1500",
    "2.9400",
    "0.1500",
    "6.1300"
  ],
  "pack_count": 1,
  "substances": [
    "Lactic Acid",
    "Calcium Chloride Dihydrate",
    "Glucose Monohydrate",
    "Glucose Anhydrous",
    "Sodium Hydrogen Carbonate",
    "Magnesium Chloride Hexahydrate",
    "Potassium Chloride",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Hemofiltrates",
  "authorisation_numbers": [
    "BE253583"
  ]
}
API referenceMCP serverPlans

See everything about lactic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console